Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Price:
10.1 USD
-1.37%
Updated:
May 9, 2024
Phathom Pharmaceuticals Inc
Total Other Income
|
Phathom Pharmaceuticals Inc
Total Other Income Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
|
Total Other Income
-$188k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Other Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Other Income
-$149m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-54%
|
|
|
Pfizer Inc
NYSE:PFE
|
Total Other Income
-$5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Total Other Income
$1.5B
|
CAGR 3-Years
48%
|
CAGR 5-Years
41%
|
CAGR 10-Years
18%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Other Income
$456.1m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
3%
|
CAGR 10-Years
20%
|
See Also
What is Phathom Pharmaceuticals Inc's Total Other Income?
Total Other Income
-188k
USD
-188k
USD
Based on the financial report for Dec 31, 2023, Phathom Pharmaceuticals Inc's Total Other Income amounts to -188k USD.
What is Phathom Pharmaceuticals Inc's Total Other Income growth rate?
Total Other Income CAGR 5Y
-30%
-30%
Over the last year, the Total Other Income growth was -71%.
You don't have any saved screeners yet
